Back
Berkshire Hills Bancorp Vs. Spyre Therapeutics Industry Stock Comparison
Sell
44
BHLB
Berkshire Hills Bancorp
Last Price:
22.18
Seasonality Move:
1.08%
Sell
28
SYRE
Spyre Therapeutics
Last Price:
22.71
Seasonality Move:
49.76%
Sell
44
Berkshire Hills Bancorp (BHLB)
is a Sell
Is Berkshire Hills Bancorp a Buy, Sell or Hold?
- The current Berkshire Hills Bancorp [BHLB] share price is $21.79. The Score for BHLB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BHLB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $23.39. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BHLB Stock Price Chart
What is Berkshire Hills Bancorp's stock price today?
-
The Berkshire Hills Bancorp share price today is $21.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BHLB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $23.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight buying pressure.
BHLB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 51.64 | Buy |
Chaikin Money Flow: | 255647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.13 - 22.25) | Buy |
Bollinger Bands (100): | (21.35 - 22.69) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.1 | Sell |
Relative Strength Index (14 RSI): | 29.8 | Sell |
Chaikin Money Flow: | 200039 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.91 - 36.47) | Sell |
Bollinger Bands (100): | (27.05 - 39.23) | Sell |
BHLB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.36 | Buy |
20-day SMA: | 21.46 | Buy |
50-day SMA: | 21.99 | Sell |
200-day SMA: | 21.95 | Sell |
8-day EMA: | 21.47 | Buy |
20-day EMA: | 21.59 | Buy |
50-day EMA: | 21.87 | Sell |
200-day EMA: | 22.34 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.36 | Sell |
20-day SMA: | 31.09 | Sell |
50-day SMA: | 33.45 | Sell |
200-day SMA: | 24.51 | Sell |
8-day EMA: | 25.8 | Sell |
20-day EMA: | 29.51 | Sell |
50-day EMA: | 32.17 | Sell |
200-day EMA: | 27.01 | Sell |
Berkshire Hills Bancorp Earnings Growth & BHLB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.07 per share, and an increase next year of $0.34 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Berkshire Hills Bancorp Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |